Home › Funds › HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC › ELV

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC reported holding 1,966,986 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$764.8M, representing 2.17% of its reported portfolio and ranking #7 among its reported holdings. HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.97M sh
Reported value held$764.80M
Portfolio Weight2.17%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC's ELV position evolved

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC first disclosed a stake in ELV in Q3 2023 at 1,722,807 shares (US$750.1M). The position peaked in Q2 2026 at 2,016,200 shares, worth US$779.7M. Across 13 filings, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,966,986 shares valued at US$764.8M — a reduction of -49,214 shares quarter over quarter.. Notable position changes include a 43% increase in Q4 2024 (shares rose 18% over the following quarter), a 44% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.72M $750.14M New
Q4 2023 1.61M $761.25M Reduce
Q1 2024 1.50M $778.09M Reduce
Q2 2024 1.31M $711.78M Reduce
Q3 2024 1.24M $646.36M Reduce
Q4 2024 1.78M $655.02M Add
Q1 2025 1.78M $773.18M Hold
Q2 2025 1.42M $551.72M Reduce
Q3 2025 2.05M $660.94M Add
Q4 2025 2.05M $719.03M Hold
Q1 2026 2.19M $641.58M Add
Q2 2026 2.02M $779.73M Reduce
Q3 2026 1.97M $764.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.31B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC held ELV?

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC's current position in ELV?

As of Q3 2026, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC holds 1.97M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $764.80M, representing 2.17% of its reported portfolio and ranking #7.

Has HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC reduced its position in ELV. The position peaked in Q2 2026 at 2.02M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.